Is SFRP-4 an Early Potential Biomarker Related to Diabetes and Hypertension in Patients with Androgenic Alopecia?
May 2018
in “
Endocrine Abstracts
”
TLDR SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.
The study investigated the potential role of Secreted Frizzled Related Protein-4 (SFRP-4) as an early biomarker for diabetes and hypertension in patients with androgenic alopecia (AGA). It involved 41 male patients with AGA and 40 male controls. Results showed that SFRP-4 levels were significantly higher in the AGA group (median 1.50 ng/ml) compared to the control group (median 0.57 ng/ml). Additionally, SFRP-4 levels positively correlated with BMI, HOMA-IR, sensitive CRP, and night pulse rate, and negatively with HDL-cholesterol in the AGA group. The findings suggested that SFRP-4 might be an early indicator of insulin resistance, diabetes, and hypertension in men with AGA.